Chondrosarcoma in the United States (1973 to 2003): An Analysis of 2890 Cases from the SEER Database

Only grade and stage are independent prognostic factors for survival in cases of chondrosarcoma. Current treatment algorithms have not improved the survival rates of patients with chondrosarcoma over the past thirty years. Routine patient surveillance following treatment should be extended to ten years of follow-up.